Raymond James Financial Services Advisors, Inc. Gsk PLC Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$42.05 - $47.77 $894,781 - $1.02 Million	21,279 Added 7.89%	290,866 $12.7 Million
Q1 2022 May 11, 2022	SELL	$40.23 - $47.74 $568,329 - $674,422	-14,127 Reduced 4.98%	269,587 $11.7 Million
Q4 2021 Feb 08, 2022	BUY	$38.88 - $45.31 $492,220 - $573,624	12,660 Added 4.67%	283,714 $12.5 Million
Q3 2021 Nov 02, 2021	SELL	$38.79 - $43.16 $3.19 Million - $3.55 Million	-82,204 Reduced 23.27%	271,054 $10.4 Million
Q2 2021 Aug 11, 2021	SELL	$36.52 - $41.46 $2.02 Million - $2.29 Million	-55,257 Reduced 13.53%	353,258 $14.1 Million
Q1 2021 May 14, 2021	BUY	$34.27 - $40.01 $1.98 Million - $2.31 Million	57,805 Added 16.48%	408,515 $14.6 Million
Q4 2020 Feb 12, 2021	SELL	$34.07 - $39.94 $359,915 - $421,926	-10,564 Reduced 2.92%	350,710 $12.9 Million
Q3 2020 Nov 04, 2020	SELL	$38.11 - $42.99 $225,573 - $254,457	-5,919 Reduced 1.61%	361,274 $13.6 Million
Q2 2020 Jul 17, 2020	BUY	$37.87 - $43.58 $1.5 Million - $1.73 Million	39,661 Added 12.11%	367,193 $15 Million
Q1 2020 Apr 21, 2020	SELL	$32.47 - $48.83 $1.76 Million - $2.65 Million	-54,255 Reduced 14.21%	327,532 $12.4 Million
Q4 2019 Feb 12, 2020	BUY	$42.0 - $48.25 $2.07 Million - $2.38 Million	49,263 Added 14.81%	381,787 $17.9 Million
Q3 2019 Nov 07, 2019	BUY	$40.46 - $43.52 $1.08 Million - $1.16 Million	26,628 Added 8.7%	332,524 $14.2 Million
Q2 2019 Aug 06, 2019	BUY	$39.4 - $42.7 $998,829 - $1.08 Million	25,351 Added 9.04%	305,896 $12.2 Million
Q1 2019 May 06, 2019	BUY	$38.57 - $42.69 $801,446 - $887,055	20,779 Added 8.0%	280,545 $11.7 Million
Q4 2018 Feb 11, 2019	BUY	$37.8 - $42.69 $591,759 - $668,311	15,655 Added 6.41%	259,766 $9.93 Million
Q3 2018 Nov 14, 2018	SELL	$39.75 - $42.69 $700,911 - $752,752	-17,633 Reduced 6.74%	244,111 $9.81 Million
Q2 2018 Jul 30, 2018	BUY	$39.61 - $42.76 $2.46 Million - $2.66 Million	62,159 Added 31.14%	261,744 $10.6 Million
Q1 2018 Apr 16, 2018	BUY	$36.18 - $40.15 $500,188 - $555,073	13,825 Added 7.44%	199,585 $7.8 Million
Q4 2017 Feb 09, 2018	SELL	$35.34 - $41.9 $890,709 - $1.06 Million	-25,204 Reduced 11.95%	185,760 $6.59 Million
Q3 2017 Oct 26, 2017	SELL	$39.44 - $41.55 $157,760 - $166,200	-4,000 Reduced 1.86%	210,964 $8.57 Million
Q2 2017 Aug 15, 2017	BUY	N/A	214,964	214,964 $9.27 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account